Abstract: IGF-I is a major hormonal regulator of differentiation, growth, proliferation, and development. It is mainly produced in the liver, the principal source of endocrine IGF-I. The main stimulus for synthesis and release of liver IGF-I is growth hormone (GH) from the anterior pituitary, and IGF-I specifically inhibits GH gene transcription and secretion via a negative feedback mechanism. As shown for species throughout phylogeny, IGF-I is also produced in extrahepatic sites, including the pituitary, and very recently, new insights have been achieved into the distinct localization of IGF-I. Bony fish pituitary preserves the embryonic compartmentalization throughout life, thus, each endocrine cell type is situated in a distinct region. This makes fish pituitary an excellent tool for morphologic investigations. IGF-I mRNA and/or peptide has been located to subtypes of endocrine cells with similar distribution patterns in lower and higher vertebrates suggesting highly conserved and, thus, important physiological roles of intrapituitary IGF-I. Since a major task of IGF-I is to prevent apoptosis and promote cell proliferation, IGF-I released from the endocrine adenohypophyseal cells may have protective and proliferative autocrine and/or paracrine effects. This is supported by the presence of the type 1 IGF receptor (IGF-1R) at all endocrine subpopulations as has been shown in rat and by the constitutive presence of IGF-I in ACTH cells in bony fish and mammals. ACTH cells probably are challenged in stressful situations by pro-apoptotic cytokines and hormones, and might, thus, have a special demand for IGF-I. The increased transient expression of IGF-I in gonadotrophs during puberty, and in subordinate males of tilapia suggests an impact in sexual differentiation and maturation, a question which has been recently underlined to be of major importance. The pronounced inter-individual differences in the IGF-I content of the GH cells may indicate that synthesis and release of IGF-I from GH cells depend on the physiological status, most likely the serum IGF-I level. Further studies should be performed to elucidate these morphofunctional observations.
IGF-I is a major hormonal regulator of differentiation, growth, proliferation, and development as has been established in mammals [1, 2] . IGF-I is mainly produced in the liver, the principal source of endocrine IGF-I. The main stimulus for synthesis and release of liver IGF-I is GH released from the anterior pituitary under the control of GHreleasing (GH-RH) and -inhibiting (somatostatin) hormone, while IGF-I specifically inhibits GH gene transcription and secretion via a negative feedback mechanism as shown in vivo and in vitro [3] [4] [5] . The suppressive action of IGF-I on GH synthesis and secretion is exerted at the pituitary level [3] and probably mediated via the IGF-1R which has been identified in clawed frog [6] , rat [7] [8] [9] [10] , ovine [11] and mouse [12] pituitary, particularly on GH cells [10, 13, 14] . In particular, the concentration of serum IGF-I stimulates or suppresses GH release from the anterior pituitary via a feedback loop in mammals and in lower vertebrates, as has been demonstrated particularly in bony fish [15] . Thus, in both mammals and bony fish the pituitary GH/liver IGF-I axis involved in the endocrine regulation of crucial physiological processes seems to exist [16, 17] .
In addition, organ-specific extrahepatic synthesis sites of IGF-I have been described in various tissues throughout phylogeny [15] indicating specific roles of local autocrine/paracrine IGF-I in numerous physiological mechanisms, such as growth, differentiation, maintenance, reproduction, and metabolism.
There is evidence that IGF-I is also expressed in the pituitary as has been shown to date for bony fish species (see below), frog [6] , rat [9, 10, [18] [19] [20] and human [21, 22] .
Thus, the question arises what the physiological function of local IGF-I in the pituitary might be? In order to get some idea of the potential role of IGF-I in pituitary it is essential to identify its localization sites. In adult mammalian adenohypophysis the diverse hormone-producing subpopulations are intermingled cell clusters forming a mosaic pattern. In rat, IGF-I mRNA has been found to be evenly distributed throughout the anterior pituitary [18, 23] and was thought to be expressed either by all endocrine or by folliculo-stellate cells [23] . While IGF-I-immunoreactive cells were described as non-hormone-producing cells in human pituitary [24] , in a mouse pituitary cell culture IGF-I immunoreactivity was confined to endocrine cells [12] , and in accordance to the latter, both IGF-I mRNA and peptide were recently localised in distinct endocrine cells of the adenohypophysis of rat [10] , human [22] and the bony fish tilapia [25] .
The hypothesis of a stimulatory role in the pituitary as raised for IGF-I [10, 12, 22, [26] [27] [28] is in agreement with observations that pituitary adenomas generally harbour a higher content of IGF-I immunoreactivity than normal pituitary [21] and secrete IGF-I [29] .
Thus, a local role of IGF-I in addition to the wellestablished endocrine feed-back mechanism on the GH cells is likely. Therefore, this review addresses the following questions: In adult mammals, the hormone-producing cell types of the adenohypophysis are arranged in a mosaic pattern [30, 31] in contrast to the embryonic state where each specific hormone-producing cell type is located within a particular compartment. This compartmentalisation is preserved in bony fish pituitary throughout a lifetime [32] [33] [34] Recently, the distinct localisation of the different cell types was clarified and showed similar distribution patterns among bony fish species [32] [33] [34] .
In bony fish pituitary, IGF-I mRNA has been detected by PCR in Cottus kazika [35] , yellow perch Perca flavescens [36] , fathead minnow [37] , and tilapia Oreochromis niloticus [25, 38] and Oreochromis mossambicus [39] . Additionally IGF-II mRNA has been detected in tilapia [38] [39] [40] . IGF-I mRNA and/or immunoreactivity were confined in tilapia to distinct endocrine cell types [25, [41] [42] [43] and some pituicytes within the neurohypophysis [25] while pituitary IGF-II has not been localised to distinct cell types to date.
Teleost fish lack a hypothalamo-hypophyseal portal system for the transport of neurohormonal regulators as it exists in mammals. Instead, a direct axonal transport connects the hypothalamic neurons and pituitary endocrine cells via the hypophyseal stalk and the neurohypophysis [33] . This direct regulatory mode is established for the gonadotrophinreleasing hormones (GnRHs) [44, 45] , and has been suggested also for the gonadotrophs (GTHs) [34, 45] . In tilapia neurohypophysis, IGF-I peptide occurred in neurosecretory axons but no IGF-I mRNA was detected which indicates that IGF-I is not produced in the neurohypophysis. Instead IGF-I mRNA was found in the hypothalamus so that also IGF-I is assumed to be transported via the axonal stalk from hypothalamic IGF-I-producing neurones as suggested for early development [42, 46] and adulthood [25] .
In tilapia adenohypophysis ( Fig. 1) , both IGF-I mRNA and peptide were present in the majority of ACTH cells [25, 41] . In -MSH cells, only IGF-I mRNA but no IGF-I peptide was detected suggesting an immediate release of IGF-I after synthesis (Fig. 1) . Whether this is the case also in other species might shed new light on the recently highlighted broad diversity of the POMC family [47] . Also in rat and human, IGF-I mRNA was localized in numerous endocrine cells and IGF-I immunoreactivity was located constantly in almost all ACTH-immunoreactive cells. Using electron microscopy, IGF-I immunoreactivity was confined to secretory granules in co-existence with ACTH immunoreactivity which indicates a concomitant release of both hormones. Thus, also in human and rat, as in tilapia, IGF-I seems to be a constituent in ACTH cells which is also supported by findings in the mouse pituitary corticotroph tumour cell line AtT-20 which has been shown to synthesise and secrete IGF-I [48] . Altogether, this points to a well-conserved expression pattern of IGF-I in the ACTH cells.
In rat, human and tilapia -TSH cells no IGF-I immunoreactivity was detected [10, 22, 25] . However, first evidence for interactions of the TSH-thyroid gland and the GH/IGF-I axis in fish exist since T3 directly stimulated the hepatic production of IGF-I in the tilapia in vitro and in vivo [49] . Whether there exist interactions also at the level of the pituitary remains to be clarified.
Whereas no IGF-I immunoreactivity was found in the prolactin cells of fish and mammalian species investigated, so far, among the amphibia, in clawed frog (Xenopus laevis) IGF-I immunoreactivity was found exclusively confined to prolactin cells.
In contrast to the exclusive location of IGF-I in some endocrine cell types, IGF-I-binding sites were found ubiquitously spread throughout the pituitary in clawed frog [6] . Furthermore, the IGF-1R has been identified in rat [7] [8] [9] [10] , ovine [11] and mouse [12] pituitary, particularly on the majority of GH cells [10, 13, 14] , numerous ACTH cells and, at lower densities, also the other hormone-producing cell types including LH and FSH cells as well as occasionally prolactin and very rarely -TSH cells, indicating a physiological impact of IGF-I for all endocrine cells [10] . fish species, such as rainbow trout [50] and American shad [51] . IGF-I mRNA appeared in the -MSH and GH regions from 30 DPF on. Later on, IGF-I mRNA was found in the majority of ACTH cells and -MSH cells in all individuals investigated where it persisted throughout life.
Around 30 DPF, IGF-I mRNA also appeared in some cells of GTH regions of female and at 50 DPF of male pituitary [42] which supports the idea that the appearance of IGF-I in the hypothalamic-pituitary-gonad axis is linked to the onset of meiosis in germ cells [52] . During puberty, the expression of IGF-I mRNA in GTH cells was pronounced in the pituitary of both sexes [42] . However, in contrast to findings of Melamed et al. [41] , neither IGF-I mRNA nor peptide were detected in GTH cells of young adult tilapia which was attributed to the reproductive stage of the individuals [25] . Indeed, elevated IGF-I gene expression was recently found in GTH regions (Fig. 1) during reproductive phases of both sexes [42] .
In the adenopituitary of dominant male tilapia, more -LH and less IGF-I mRNA was detected than in normal males while in subordinate males the opposite was present suggesting a role of IGF-I also in sexual competition and social status [43] . The latter is consistent with observations in blue gourami, where -LH mRNA was higher in sexually active males when compared to inactive individuals. In contrast, -FSH mRNA levels were significantly higher in mature than in juvenile males independent of the sexual activity which generally supports the involvement of -FSH in spermatogenesis and of -LH in spermiogenesis [53] . Thus, there is increasing evidence for the interference of behavior and social dominance with the hormonal system, not only at the level of steroid receptor expression in brain and pituitary [e.g., 54] but also in the hormone content of the gonadotrophs [43] which might explain the broad variance in IGF-I expression in -LH cells as previously observed in adult tilapia [41] . In agreement with the IGF-1R located to rat LH and FSH cells [10] , IGF-I has been postulated as important factor for GTH cell action also in mammals since exposure of rat pituitary cells to IGF-I markedly stimulated basal LH and FSH release [55] , and augmented basal and Gn-RH-stimulated release of LH in vitro [56] [57] [58] [59] whereby in pig the IGF-I-induced increase in basal LH release changed during the oestrous cycle [60] .
There is some, but controversial, evidence for a similarly important role in bony fish as most recently emphasized [61, 62] . In primary cultured pituitary cells of eel, salmon and rainbow trout, IGF-I increased -LH cell content and release [63] , raised the Gn-RH-stimulated -FSH release [64, 65] and the intracellular -FSH content while the effect on -LH cells was less pronounced [64] . Similarly, in primary culture of zebrafish pituitary, IGF-I dose-dependently stimulated gene expression of -FSH but not -LH [66] while in masu salmon IGF-I directly stimulated both -FSH and -LH expression and release and modulated GnRH-induced GTH gene expression particularly during early gametogenesis, sexual maturation and reproductive stages [67, 68] which demonstrates that the role of IGF-I in the GTH cells differs among species. Potentiating effects of IGF-I on FSH responses to GnRH were highest in early gametogenesis [69] . Thus, -FSH seems to be generally more susceptible to Fig. (1) . Schematic drawing of the localisation of IGF-I mRNA/immunoreactivity in tilapia adenohypophysis and assumed autocrine/paracrine functions within the diverse endocrine cell types. Schemes depicted after [25, 34, 42] . RPD: rostral pars distalis. PPD: proximal pars distalis. PI: pars intermedia. PN: pars nervosa.
influences by IGF-I, but this demands further studies, especially during different reproductive phases.
What is the role of IGF-I in the diverse endocrine cells?
The results indicate that synthesis of IGF-I in the pituitary most likely occurs in endocrine cells with similar distribution patterns in mammals and bony fish suggesting a highly conserved local role of IGF-I in the pituitary. Since a major physiological role of IGF-I is to prevent the onset of apoptosis and promote cell proliferation [70] , IGF-I released from the different endocrine cells may have widespread local functions exerted in an either autocrine or paracrine manner (Fig. 1) . This hypothesis gets support by the presence of the IGF-1R at cells of all endocrine subpopulations as shown in rat [10] and by the finding that IGF-I stimulated proliferation of cultured mouse endocrine pituitary cells [12] and prevented apoptosis in rat pituitary [20, 71] .
Since in the adenohypophysis of tilapia, rat and human, IGF-I-immunoreactivity was found in the vast majority of the ACTH cells [25, 41] , IGF-I seems to be constitutively synthesized in ACTH cells [10, 22, 25] and to be concomitantly released with ACTH [10, 22] . However, no effect of IGF-I on ACTH secretion was observed after in vivo application in human although it decreased GH secretion but did not modify the corticotroph responsiveness to CRH [72] . Correspondingly, in rat pituitary cultures IGF-I directly inhibited basal and theophylline-stimulated GH release but did not alter ACTH release [73] , and IGF-I exerted no significant effect on basal or CRH-stimulated ACTH release from ovine pituitary [74] .
However, the constant presence of IGF-I in ACTH cells suggests other physiological options. As discussed above, IGF-I in mammalian pituitary may serve as a maintenance and proliferation factor when released from endocrine cells. On this basis one can speculate on a particular need of the ACTH cells for IGF-I. Involvement of ACTH cells in stressful situations may lead to challenge with proapoptotic cytokines and thus, require IGF-I to protect against apoptosis. Most recently, neuroendocrine-immune interactions were thoroughly reviewed and the need for more investigations of these interactions especially in central organs was emphasized [75] .
As further demonstrated in tilapia, rat and human, IGF-I also occurred in a varying number of GH cells in pituitary. In tilapia, IGF-I mRNA was present in the majority of GH cells during early development [42] , the latter suggesting an auto/paracrine function of IGF-I in the proliferation of GH cells (Fig. 1) . In later life, however, the number of GH cells containing IGF-I markedly varied among the individuals of different species investigated [10, 22, 25] which explains why IGF-I immunorectivity could not be detected in tilapia GH cells in an earlier study [41] . Thus, there is evidence for a local negative feedback mechanism on the pituitary GH cells (Fig. 2) in addition to the well-established endocrine route: in vivo experiments in rat showed an inverse relationship between circulating IGF-I and pituitary GH levels [19, 76, 77] , and IGF-I inhibited basal and GH-RHstimulated GH expression and secretion in rat dispersed anterior pituitary cells [78] , rat and mouse pituitary cell cultures [27, 55, [79] [80] [81] , human somatotrophinomas [82] , MtT/S somatotrophic cells [4] , the rat pituitary cell line GH3 [83] , and in a bony fish in vitro model of striped bass (Morone saxatilis), white perch (Morone americana) and tilapia (Oreochromis mossambicus) [84] , Arctic charr [85] , rainbow trout [86] and eel [87] . Very recently, in a pituitary in vitro culture from hybrid striped bass (Morone saxatilis x M. chrysops) reared under different environmental conditions (seasonally-based feeding and temperature manipulations) IGF-I inhibited GH release regardless of the metabolic state [88] while in GH-overexpressing transgenic Coho salmon elevated IGF-I serum levels did not significantly suppress pituitary GH expression, a finding which coincided with elevated pituitary IGF-I mRNA levels [89] . Neither did the dropped IGF-I serum levels in GHoverexpressing transgenic tilapia [90] significantly alter pituitary GH expression (as in the Coho salmon mentioned above only mild suppression was measured) [91] while IGF-I (and also IGF-II) gene expressions were elevated at the pituitary level [40] .
Whereas a positive correlation of body size and plasma IGF-I concentration had been postulated in wild type and GH-overexpressing Coho salmon and tilapia [89, 92, 93] the findings in the growth-enhanced GH-transgenic tilapia [40, 90, 91] provide more support for the idea that growth may be less due to endocrine mechanisms but to local IGF-I production as has been demonstrated in mice using the Cre/loxP recombination system to delete the IGF-I gene exclusively in the liver [94, 95] .
Several studies have shown that estrogen regulates GH synthesis and secretion in tilapia [96, 97] , rat and human [98] , the amount of circulating IGF-I in GH-deficient adults [99] and fish [96] , and IGF-I mRNA and IGF-I binding in rat pituitary [23] . However, no obvious difference was observed between male and female rats and this was also valid for the portion of GH cells containing IGF-I immunoreactivity [10] . More studies are needed to expand knowledge of the local effects of environmental estrogens on fish pituitary as a central regulatory organ of virtually all physiological processes also in bony fish.
SUMMARY AND CONCLUSIONS
Altogether, the results in bony fish and mammals indicate a conservative evolution of the pituitary IGF-I system and, thus, particular phylogenetically well preserved physiological functions of local IGF-I. It is assumed that the protective and proliferative effects of IGF-I in pituitary may be exerted not only by circulating but also by local IGF-I released from endocrine cells of the adenohypophysis, and that there exist specific roles for local IGF-I in the pituitary, such as stimulating endocrine cell proliferation, regulating synthesis and release of pituitary hormones, and protecting endocrine cells from apoptosis, especially the ACTH cells. Specific tasks seem to exist for IGF-I in the GTH cells during puberty, reproductive phases and in social competition. In order to enlighten the potential physiological role(s) of IGF-I in distinct endocrine cells, as they have been assumed above, further in vitro studies should be performed with cell lines or culture of primary tissues throughout phylogeny. In addition, the following in vivo experiments in bony fish may be helpful:
1. GH cells: Detailed investigations on IGF-I in GH cells during early and later development, such as phases of rapid growth, as well as starvation and refeeding experiments should be performed.
2. ACTH cells: Exposure of fish to stressful situations, such as salinity change or social stress, may help to clarify whether the expression of IGF-I in ACTH cells indeed is constitutive or altered under stress. 
